» Articles » PMID: 15287903

Effects of Phosphorylation by Protein Kinase A on Binding of Catecholamines to the Human Tyrosine Hydroxylase Isoforms

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2004 Aug 4
PMID 15287903
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Tyrosine hydroxylase (TyrH), the catalyst for the key regulatory step in catecholamine biosynthesis, is phosphorylated by cAMP-dependent protein kinase A (PKA) on a serine residue in a regulatory domain. In the case of the rat enzyme, phosphorylation of Ser40 by PKA is critical in regulating the enzyme activity; the effect of phosphorylation is to relieve the enzyme from inhibition by dopamine and dihydroxyphenylalanine (DOPA). There are four isoforms of human tyrosine hydroxylase (hTyrH), differing in the size of an insertion after Met30. The effects of phosphorylation by PKA on the binding of DOPA and dopamine have now been determined for all four human isoforms. There is an increase of about two-fold in the Kd value for DOPA for isoform 1 upon phosphorylation, from 4.4 to 7.4 microM; this effect decreases with the larger isoforms such that there is no effect of phosphorylation on the Kd value for isoform 4. Dopamine binds more much tightly, with Kd values less than 3 nM for all four unphosphorylated isoforms. Phosphorylation decreases the affinity for dopamine at least two orders of magnitude, resulting in Kd values of about 0.1 microM for the phosphorylated human enzymes, due primarily to increases in the rate constant for dissociation of dopamine. Dopamine binds about two-fold less tightly to the phosphorylated isoform 1 than to the other three isoforms. The results extend the regulatory model developed for the rat enzyme, in which the activity is regulated by the opposing effects of catecholamine binding and phosphorylation by PKA. The small effects on the relatively high Kd values for DOPA suggest that DOPA levels do not regulate the activity of hTyrH.

Citing Articles

Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation.

Bueno-Carrasco M, Cuellar J, Flydal M, Santiago C, Krakenes T, Kleppe R Nat Commun. 2022; 13(1):74.

PMID: 35013193 PMC: 8748767. DOI: 10.1038/s41467-021-27657-y.


DOPA Homeostasis by Dopamine: A Control-Theoretic View.

Kleppe R, Waheed Q, Ruoff P Int J Mol Sci. 2021; 22(23).

PMID: 34884667 PMC: 8657751. DOI: 10.3390/ijms222312862.


Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum.

Chitre N, Wood B, Ray A, Moniri N, Murnane K Neuropharmacology. 2020; 167:107976.

PMID: 32001239 PMC: 7110909. DOI: 10.1016/j.neuropharm.2020.107976.


Manganese tissue accumulation and tyrosine hydroxylase immunostaining response in the Neotropical freshwater crab, Dilocarcinus pagei, exposed to manganese.

Ponzoni S Invert Neurosci. 2017; 17(2):5.

PMID: 28451884 DOI: 10.1007/s10158-017-0198-7.


Regulation of tyrosine hydroxylase is preserved across different homo- and heterodimeric 14-3-3 proteins.

Ghorbani S, Fossbakk A, Jorge-Finnigan A, Flydal M, Haavik J, Kleppe R Amino Acids. 2016; 48(5):1221-9.

PMID: 26825549 PMC: 4833811. DOI: 10.1007/s00726-015-2157-0.


References
1.
Andersson K, Vassort C, Brennan B, Que Jr L, Haavik J, Flatmark T . Purification and characterization of the blue-green rat phaeochromocytoma (PC12) tyrosine hydroxylase with a dopamine-Fe(III) complex. Reversal of the endogenous feedback inhibition by phosphorylation of serine-40. Biochem J. 1992; 284 ( Pt 3):687-95. PMC: 1132593. DOI: 10.1042/bj2840687. View

2.
Haycock J . Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J Biol Chem. 1990; 265(20):11682-91. View

3.
Haycock J, Ahn N, Cobb M, KREBS E . ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc Natl Acad Sci U S A. 1992; 89(6):2365-9. PMC: 48658. DOI: 10.1073/pnas.89.6.2365. View

4.
Le BOURDELLES B, Horellou P, Le Caer J, Denefle P, Latta M, Haavik J . Phosphorylation of human recombinant tyrosine hydroxylase isoforms 1 and 2: an additional phosphorylated residue in isoform 2, generated through alternative splicing. J Biol Chem. 1991; 266(26):17124-30. View

5.
Haavik J, Le BOURDELLES B, Martinez A, Flatmark T, Mallet J . Recombinant human tyrosine hydroxylase isozymes. Reconstitution with iron and inhibitory effect of other metal ions. Eur J Biochem. 1991; 199(2):371-8. DOI: 10.1111/j.1432-1033.1991.tb16133.x. View